These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 10206323

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures.
    Hirsch-Ernst KI, Ziemann C, Rustenbeck I, Kahl GF.
    Toxicology; 2001 Oct 05; 167(1):47-57. PubMed ID: 11557129
    [Abstract] [Full Text] [Related]

  • 23. Homozygous disruption of the mdrla P-glycoprotein gene affects blood-nerve barrier function in mice administered with neurotoxic drugs.
    Saito T, Zhang ZJ, Ohtsubo T, Noda I, Shibamori Y, Yamamoto T, Saito H.
    Acta Otolaryngol; 2001 Sep 05; 121(6):735-42. PubMed ID: 11678173
    [Abstract] [Full Text] [Related]

  • 24. Cyclosporin A has low potency as a calcineurin inhibitor in cells expressing high levels of P-glycoprotein.
    Fakata KL, Elmquist WF, Swanson SA, Vorce RL, Prince C, Stemmer PM.
    Life Sci; 1998 Sep 05; 62(26):2441-8. PubMed ID: 9651111
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET.
    Bart J, Willemsen AT, Groen HJ, van der Graaf WT, Wegman TD, Vaalburg W, de Vries EG, Hendrikse NH.
    Neuroimage; 2003 Nov 05; 20(3):1775-82. PubMed ID: 14642487
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. P-glycoprotein limits the brain penetration of olopatadine hydrochloride, H1-receptor antagonist.
    Mimura N, Nagata Y, Kuwabara T, Kubo N, Fuse E.
    Drug Metab Pharmacokinet; 2008 Nov 05; 23(2):106-14. PubMed ID: 18445990
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier.
    Bourasset F, Cisternino S, Temsamani J, Scherrmann JM.
    J Neurochem; 2003 Sep 05; 86(6):1564-7. PubMed ID: 12950465
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography.
    Hendrikse NH, Schinkel AH, de Vries EG, Fluks E, Van der Graaf WT, Willemsen AT, Vaalburg W, Franssen EJ.
    Br J Pharmacol; 1998 Aug 05; 124(7):1413-8. PubMed ID: 9723952
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice.
    van Asperen J, Schinkel AH, Beijnen JH, Nooijen WJ, Borst P, van Tellingen O.
    J Natl Cancer Inst; 1996 Jul 17; 88(14):994-9. PubMed ID: 8667431
    [Abstract] [Full Text] [Related]

  • 37. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4.
    Takanaga H, Ohnishi A, Yamada S, Matsuo H, Morimoto S, Shoyama Y, Ohtani H, Sawada Y.
    J Pharmacol Exp Ther; 2000 Apr 17; 293(1):230-6. PubMed ID: 10734174
    [Abstract] [Full Text] [Related]

  • 38. Pharmacoproteomics-based reconstruction of in vivo P-glycoprotein function at blood-brain barrier and brain distribution of substrate verapamil in pentylenetetrazole-kindled epilepsy, spontaneous epilepsy, and phenytoin treatment models.
    Uchida Y, Ohtsuki S, Terasaki T.
    Drug Metab Dispos; 2014 Oct 17; 42(10):1719-26. PubMed ID: 25061162
    [Abstract] [Full Text] [Related]

  • 39. Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein.
    Adachi Y, Suzuki H, Sugiyama Y.
    Pharm Res; 2001 Dec 17; 18(12):1660-8. PubMed ID: 11785684
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.